Andrew D Berti

7PUBLICATIONS
7CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Medical bacteriologyMicrobial geneticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 18, 2025
Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates.

Callan R Bleick, Sean R Van Helden, Andrew D Berti

|Feb 26, 2025
Prophage ϕSA169 Enhances Vancomycin Persistence in Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA).

Yi Li, Andrew D Berti, Wessam Abdelhady

|Oct 29, 2024
It takes two to tango: Preserving daptomycin efficacy against daptomycin-resistant MRSA using daptomycin-phage co-therapy.

Casey L Madison, Anja S J Steinert, Corrin E Luedeke

|Dec 23, 2022
Antimicrobial Efficacy against Antibiotic-Tolerant <i>Staphylococcus aureus</i> Depends on the Mechanism of Antibiotic Tolerance.

Emily M Meredith, Lauren T Harven, Andrew D Berti

|Nov 11, 2022
Editorial: <i>Antibiotics</i> Special Issue on Pharmacokinetic/Pharmacodynamic Models of Antibiotics.

Razieh Kebriaei, Andrew D Berti

|Oct 20, 2021
Rapid resistance development to three antistaphylococcal therapies in antibiotic-tolerant staphylococcus aureus bacteremia.

Christopher R Miller, Jonathan M Monk, Richard Szubin

Pageof 2

Frequent Collaborators

2 joint publications

Razieh Kebriaei

1 joint publications

Victoria Bingley

1 joint publications

Callan R Bleick

1 joint publications

Sean R Van Helden